Trinity Biotech Plc (TRIB) Reports Q4 EPS of $0.29

Trinity Biotech Plc (NASDAQ: TRIB) reported Q4 EPS of $0.29, versus $0.66 reported last year. Revenue for the quarter came in at $271.2 million, versus $251 million reported last year.

For earnings history and earnings-related data on Trinity Biotech Plc (TRIB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery